Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Other Non-Current Assets (2020 - 2025)

Maxcyte (MXCT) has disclosed Other Non-Current Assets for 6 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets rose 145.58% to $2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.6 million, a 145.58% increase, with the full-year FY2024 number at $1.5 million, up 294.85% from a year prior.
  • Other Non-Current Assets was $2.6 million for Q3 2025 at Maxcyte, down from $2.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.8 million in Q2 2025 to a low of $295000.0 in Q1 2024.
  • A 5-year average of $1.1 million and a median of $864750.0 in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: soared 834.22% in 2021, then crashed 62.15% in 2023.
  • Maxcyte's Other Non-Current Assets stood at $316700.0 in 2021, then soared by 155.45% to $809000.0 in 2022, then tumbled by 52.04% to $388000.0 in 2023, then surged by 294.85% to $1.5 million in 2024, then surged by 68.47% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Other Non-Current Assets are $2.6 million (Q3 2025), $2.8 million (Q2 2025), and $1.9 million (Q1 2025).